BENEDETTI, MICHELE
 Distribuzione geografica
Continente #
EU - Europa 9.668
NA - Nord America 6.975
AS - Asia 5.709
SA - Sud America 964
Continente sconosciuto - Info sul continente non disponibili 295
AF - Africa 152
OC - Oceania 6
AN - Antartide 1
Totale 23.770
Nazione #
US - Stati Uniti d'America 6.593
IT - Italia 3.918
SG - Singapore 2.488
IE - Irlanda 1.959
RU - Federazione Russa 1.585
CN - Cina 1.076
BR - Brasile 802
HK - Hong Kong 800
VN - Vietnam 506
SE - Svezia 498
UA - Ucraina 445
FR - Francia 309
IN - India 280
DE - Germania 242
GB - Regno Unito 184
CA - Canada 170
FI - Finlandia 164
KR - Corea 110
BD - Bangladesh 98
NL - Olanda 92
MX - Messico 85
AR - Argentina 68
PL - Polonia 63
ZA - Sudafrica 56
TR - Turchia 50
BE - Belgio 47
JP - Giappone 46
ID - Indonesia 38
IQ - Iraq 36
SN - Senegal 34
ES - Italia 33
PH - Filippine 30
AE - Emirati Arabi Uniti 26
EC - Ecuador 26
CR - Costa Rica 23
CH - Svizzera 21
LT - Lituania 21
PK - Pakistan 20
AT - Austria 16
SV - El Salvador 16
CO - Colombia 15
CW - ???statistics.table.value.countryCode.CW??? 14
CZ - Repubblica Ceca 13
EG - Egitto 13
TT - Trinidad e Tobago 13
CL - Cile 12
EE - Estonia 12
JM - Giamaica 12
JO - Giordania 12
MA - Marocco 12
UZ - Uzbekistan 12
VE - Venezuela 12
GP - Guadalupe 11
HN - Honduras 11
KE - Kenya 11
PE - Perù 11
PR - Porto Rico 11
SA - Arabia Saudita 10
IR - Iran 9
MY - Malesia 9
PY - Paraguay 9
RO - Romania 9
IL - Israele 8
TN - Tunisia 8
AZ - Azerbaigian 7
DZ - Algeria 7
GT - Guatemala 7
GR - Grecia 6
NP - Nepal 6
AL - Albania 5
BG - Bulgaria 5
DO - Repubblica Dominicana 5
KW - Kuwait 5
NI - Nicaragua 5
RS - Serbia 5
UY - Uruguay 5
AU - Australia 4
ET - Etiopia 4
PS - Palestinian Territory 4
BH - Bahrain 3
BO - Bolivia 3
BZ - Belize 3
EU - Europa 3
HR - Croazia 3
OM - Oman 3
QA - Qatar 3
SY - Repubblica araba siriana 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
CG - Congo 2
DK - Danimarca 2
GD - Grenada 2
MK - Macedonia 2
MN - Mongolia 2
PT - Portogallo 2
SC - Seychelles 2
AG - Antigua e Barbuda 1
AM - Armenia 1
AQ - Antartide 1
BM - Bermuda 1
Totale 23.469
Città #
Lecce 2.118
Dublin 1.960
Singapore 832
Ashburn 754
Hong Kong 707
San Jose 686
Council Bluffs 603
Moscow 511
Chandler 367
Beijing 292
Jacksonville 254
Dallas 227
New York 226
Wayanad 184
Milan 179
Los Angeles 157
Ho Chi Minh City 152
Princeton 133
Hanoi 121
Lauterbourg 120
Rome 120
Santa Clara 119
Seoul 108
São Paulo 93
Munich 92
Des Moines 84
Foggia 84
Central District 72
Bari 65
Orem 53
Phoenix 52
Montreal 49
Warsaw 49
Brooklyn 48
Frankfurt am Main 48
Atlanta 47
Lequile 47
Ann Arbor 45
The Dalles 44
Wilmington 43
Brussels 42
San Pietro Vernotico 42
Turin 42
Stockholm 39
Tokyo 39
Bologna 37
Chicago 37
Copertino 37
Naples 37
Denver 36
Dakar 34
Johannesburg 34
Boston 33
London 33
West Jordan 33
Mexico City 31
Chennai 29
Haiphong 29
Brasília 28
Ogden 28
Boardman 27
Poplar 27
Helsinki 26
Seattle 25
Amsterdam 24
Ankara 24
Da Nang 24
Miano 24
North Bergen 24
Florence 23
Houston 23
Rio de Janeiro 23
Biên Hòa 22
Toronto 22
Mumbai 21
Washington 21
Charlotte 19
Jinan 18
San Mateo 18
Buffalo 17
Catania 17
Columbus 17
Manchester 17
San José 17
Turku 16
Guangzhou 15
North Charleston 14
San Francisco 14
Willemstad 14
Augusta 13
Baghdad 13
Bakersfield 13
Belo Horizonte 13
City of London 13
Maastricht 13
Ortelle 13
San Salvador 13
Verona 13
Zhengzhou 13
Curitiba 12
Totale 13.380
Nome #
Studio dell'interferenza di ioni metallici nel meccanismo d'azione dell'artemisinina 1.116
Design and Application of Cisplatin-Loaded Magnetic Nanoparticle Clusters for Smart Chemotherapy 288
Evaluation of the Antitumor Effects of Platinum-Based [Pt(η1-C2H4-OR)(DMSO)(phen)]+ (R = Me, Et) Cationic Organometallic Complexes on Chemoresistant Pancreatic Cancer Cell Lines 268
195Pt and 15N NMR Data in Square Planar Platinum(II) Complexes of the Type [Pt(NH3)aXb]n (Xb = Combination of Halides): “NMR Effective Molecular Radius” of Coordinated Ammonia 258
[PtCl(h1-CH2-CH2OR)(N^N)] and [PtCl(h2-CH2-CH2)(N^N)]+, N^N = dinitrogen ligand, complexes. Sterical and electronic effects evidenced by NMR analysis. 246
Cell uptake and processing of metalated purines: a new possible path to antitumor and antiviral drugs 245
N7-platinated ribonucleotides are not incorporated by RNA polymerases. New perspectives for a rational design of platinum antitumor drugs 238
73Ge, 119Sn and 207Pb: general cooperative effects of single atom ligands on the NMR signals observed in tetrahedral [MXnY4−n] (M = Ge, Sn, Pb; 1 ≤ n ≤ 4; X, Y = Cl, Br, I) coordination compounds of heavier XIV group elements 236
Assessing the Effectiveness of Vermi-Liquids as a Sustainable Alternative to Inorganic Nutrient Solutions in Hydroponic Agriculture: A Study on Diplotaxis muralis 228
Platinated Nucleotides are Substrates for the Human Mitochondrial Deoxynucleotide Carrier (DNC) and DNA Polymerase g: Relevance for the Development of New Platinum-Based Drugs. 225
Adsorption of the cis-[Pt(NH3)2(P2O7)](2-) (phosphaplatin) on hydroxyapatite nanocrystals as a smart way to selectively release activated cis-[Pt(NH3)2Cl2] (cisplatin) in tumor tissues 223
General cooperative effects of single atom ligands on a metal: a (195)Pt NMR chemical shift as a function of coordinated halido ligands' ionic radii overall sum 221
Cell metabolism of metalated purines 221
1H-NMR metabolomic study of SKOV-3 cells, response to the [Pt(O,O′-acac)(γ-acac)(DMS)] treatment 221
Antitumor and antimigration effects of a new Pt compound on neuroblastoma cells 220
Cell uptake and processing of platinated nucleotides 220
Corrigendum: Platinated Nucleotides are Substrates for the Human Mitochondrial Deoxynucleotide Carrier (DNC) and DNA Polymerase γ: Relevance for the Development of New Platinum-Based Drugs (ChemistrySelect, (2016), 1, (4633-4637), 10.1002/slct.201600961) 219
Alkyl-vinyl-ethers from alcoholic substrates and the Zeise's salt, via square planar [PtCl(N-N)(eta(1)-CH2CH2OR)] complexes 218
An Overview of Altered Pathways Associated with Sensitivity to Platinum-Based Chemotherapy in Neuroendocrine Tumors: Strengths and Prospects 217
Hydroxyapatite nanocrystals and modulation of the antitumor activity of phosphaplatins 217
Insertion of alkynes into Pt–X bonds of square planar [PtX2(N^N)] (X = Cl, Br, I) complexes 215
Cytotoxicity of new organometallic Pt(II)-complexes containing 1,10-phenantroline 212
Activation of C-H Bond in the Coordination Sphere of Platinum(II) 209
Response of cisplatin resistant SkOV-3 cells to [PT(O,O'-Acac)(γ-Acac)(DMS)] Treatment revealed by a metabolomic 1H-NMR study 208
Progetto inerente lo svolgimento della tesi di Dottorato in Sintesi Chimica ed Enzimatica Applicata, XXII ciclo, presentato dal Dottorando Cosimo Ducani 207
Cationic olefin complexes of platinum(II): Aspects of availability and reactivity 206
Modulation of properties in analogues of Zeise's anion on changing the ligand trans to ethene. X-Ray crystal structures of trans-[PtCl2(OH)(eta(2)-C2H4)](-) and trans-[PtCl2(eta(1)-CH2NO2)(eta(2)-C2H4)](-) 204
Experimental evidence that a DNA polymerase can incorporate N7-platinated guanines to give platinated DNA 202
[Pt(dien)(N7-G)] transport by the mitochondrial deoxynucleotide carrier: possible role in the cytotoxicity of platinated purines 198
Insertion of terminal alkyne into Pt–N bond of the square planar [PtI2(Me2phen)] complex 198
A NMR-Based Metabolomic Approach to Investigate the Antitumor Effects of the Novel [Pt(η1-C2H4OMe)(DMSO)(phen)]+ (phen = 1,10-Phenanthroline) Compound on Neuroblastoma Cancer Cells 197
Antitumor Effects Induced by the Promising Drug [Pt(O,O′-acac)(γ-acac)(DMS)] in Cisplatin Resistant Epithelial Ovarian Carcinoma Cell Line (SKOV-3): a 1H NMR Metabolomic Study 197
A way to trap elusive cationic olefin complexes of Platinum (II) 194
Transport of Platinum bonded nucleotides into proteoliposomes, mediated by Drosophila melanogaster thiamine pyrophosphate carrier protein (DmTpc1) 193
Basic coordination chemistry relevant to DNA adducts formed by the cisplatin anticancer drug. NMR studies on compounds with sterically crowded chiral ligands 192
New method for the synthesis of [PtCl{η1-CH2C(O)R}(N-N)] ketonyl derivatives starting from the Zeise’s salt 188
Bioaugmentation: A Novel Strategy To Cope With Environmental Impacts Of Agrochemicals 187
Progetto inerente lo svolgimento della tesi di dottorato della Dottoranda Daniela Antonucci, nell’ambito del Dottorato in Sintesi Chimica ed Enzimatica Applicata (XXIV ciclo). 186
Cooperative Effects of Atomic Ligands on the NMR Signals of [AX4] (A = C, Si, Ge, Sn, Pb; X4 = Combination of Four Halido and Hydrido ligands) Coordination Compounds 186
Possible incorporation in DNA of free N7-platinated guanines by DNA polymerases. 185
Polydopamine-functionalized superparamagnetic clusters as potential magnetic carriers for delivery of Platinum anticancer drugs 185
Water-soluble Organometallic Analogues of Oxaliplatin with Cytotoxic and Anticlonogenic Activity 184
Reviews: Vermicompost: Enhancing Plant Growth and Combating Abiotic and Biotic Stress 183
Studio in vitro della possibile platinazione di acidi nucleici operata da polimerasi e complessi di Pt(II) con basi puriniche 183
Reactivity of [PtCl(eta(2)-C2H4)(N-N)](+), N-N = diimine ligand, with phenol derivatives and first comparison between single crystal X-ray structures of syn- and anti-[Pt(N-N)(phenolate)(2)] rotamers in the solid state 183
Possible involvement of free platinated purines in the cisplatin mechanism of action. 182
Metalated nucleotide chemisorption on hydroxyapatite 182
Photoactivated aqueous nanocolloids of Platicur: NMR metabolomic study of treated HeLa cancer cells 181
NMR effective radius of hydrogen in XIV group hydrides evaluated by NMR spectroscopy 179
NMR-based metabolomic analyses of cisplatin resistant SKOV-3 cell line response to [Pt (O,O′-acac)(γ-acac)(DMS)], Ptac2S, treatment: comparison to cisplatin 179
Possible incorporation of free N7-platinated guanines in DNA by DNA polymerases, relevance for the cisplatin mechanism of action. 178
Is hydrogen electronegativity higher than Pauling's value? New clues from the 13C and 29Si NMR chemical shifts of [CHF3] and [SiHF3] molecules 177
Synthesis and comparative evaluation of the cytotoxic activity of cationic organometallic complexes of the type [Pt(η1-CH2-CH2-OR)(DMSO)(phen)]+ (R = Me, Et, Pr, Bu) 176
New synthetic methods for organometallic ketonyl derivatives of the type [PtCl{h1-CH2C(O)R}(N-N)] starting from the Zeise’s salt 174
Synthesis and characterization of new water-soluble organometallic complexes of the type [PtL(h1-C2H4OMe)(N^N)] (L = NH3, DMSO; N^N = dinitrogen ligand) with potential antitumor activity 172
Is hydrogen electronegativity higher than Pauling’s value? New clues from the 13C and 29Si NMR chemical shifts of [AHF3] (A = C, Si) compounds 170
Square-Planar PtII versus Octahedral PtIV Halido Complexes:195Pt NMR Explained by a Simple Empirical Approach 169
Compatibility of Nucleobases Containing Pt(II) Complexes with Red Blood Cells for Possible Drug Delivery Applications 166
The effect of pressure on CD spectra of the chiral octahedral transition metal complexes Lambda-, Delta- and (Lambda, Delta)[Cr[(+)(S)(S)Mebdtp]3] 166
POSSIBLE INVOLVEMENT OF FREE PLATINATED PURINES IN THE MECHANISM OF ACTION OF CISPLATIN 166
New insights on the reactivity of [Pt(h2-C2H4)Cl(N-N)]+, N-N = diimine ligand, with phenolate derivatives. Single crystal X-ray structures of syn- and anti-[Pt(N-N)(4-Me-C6H4O)2] rotamers 165
First evidence for N7-Platinated Guanosine derivatives cell uptake mediated by plasma membrane transport processes 165
Chiral Discrimination in Platinum Anticancer Drugs 164
[Pt(O,O′-acac)(γ-acac)(DMS)] 163
General cooperative effects of single atom ligands on the NMR signals of [AXn] (A = C, Si, Ge, Sn, Pb, Pt; Xn = combination of n halido and hydrido ligands; n = 4-6) coordination compounds 163
X-ray Structure and Circular Dichroism of Pure Rotamers of Bis[guanosine-5′-monophosphate(-1)](N,N,N′,N,′-tetramethylcyclohexyl-1,2-diamine)platinum(II) Complexes That Have R,R and S,S Configurations at the Asymmetric Diamine 162
Novel Pt (II) Complexes With Anticancer Activity Against Pancreatic Ductal Adenocarcinoma Cells 159
Platinum-Nucleos(t)ide Compounds as Possible Antimetabolites for Antitumor/Antiviral Therapy: Properties and Perspectives 158
Chiral discrimination in the formation reaction and at equilibrium for N,N,N′,N′-tetramethyl-1,2-diaminocyclohexane-PtG2 complexes 158
Transfer of Chirality by Dithiophosphate Ligands and Chiral Discrimination in the Stereoselective Formation of Square-Planar Ni(II) Complexes 158
Different Cytotoxic Effects of Cisplatin on Pancreatic Ductal Adenocarcinoma Cell Lines 156
The first pure Lambda HT rotamer of a complex with a cis-[metal(nucleotide)(2)] unit: A cis-[Pt(amine)(2)(nucleotide)(2)] Lambda HT rotamer with unique molecular structural features 156
Induced CD on the d-d transitions of square planar MS4 chromophoric groups of Ni(II) complexes with enantiomeric dithiophosphate ligands: (+)589(-)(CD662)Ni[(R,R)bdtp]2, and (-)589 (+)(CD662)Ni[(S,S)bdtp]2 154
Configurational equilibrium and CD spectra under pressure of chiral octahedral complexes: Λ- and Δ-Cr[(-)(R,R)bdtp]3 154
Synthesis and structural characterization of polymeric [Cd(glycyl-L-aspartate)(H2O)]. 154
METALATED PURINES AS A NEW POSSIBLE PATH TO ANTITUMOR AND ANTIVIRAL DRUGS 151
Vermibiochar: A Novel Approach for Reducing the Environmental Impact of Heavy Metals Contamination in Agricultural Land 150
NMR-based metabolomics in metal-based drug research 149
Transfer of chirality in complexes with D-3 symmetry: Kinetics of the formation reaction of chiral tris-[O,O'-bis-(2-methylbutyl)-dithiophosphato] chromium(III) complexes (Lambda, Delta)-[Cr{(+/-)-Mebdtp}(3)], Delta-(+)(589)- and Lambda-(-)(589)-[Cr{(+)-(S)(S)-Mebdtp}(3)] 147
Wireframe DNA Origami for the Cellular Delivery of Platinum(II)-Based Drugs 146
Platinum metalla-chromane complexes as tentative vitamin E biomimetic Trojan horses 146
Pauling Electronegativity On/Off Effects Assessed by13C and 29SiNMR Spectroscopic Analysis 145
X-ray structures versus NMR signals in pentacoordinate [PtX 2 (η 2-CH2=CH2)(Me2phen)] (X= Cl, Br, I) complexes 144
Synthesis, Characterization, and Cytotoxicity Evaluation of Novel Water-Soluble Cationic Platinum(II) Organometallic Complexes with Phenanthroline and Imidazolic Ligands. 143
Highly selective metal mediated ortho-alkylation of phenol. First platinum containing organometallic chromane analogues 143
MOLECULAR MERGING VERSUS MOLECULAR LINKING: NEW BIOINORGANIC PERSPECTIVES OF DRUG DESIGN. 142
The effect of pressure on circular dichroism spectra of a chiral helicoidal chromium complex 140
Stereospecific alkylation of phenols and synthesis of (aryloxo)platinum(II) complexes with N-donor ligands 140
Visible light-activated water-soluble Platicur nanocolloids: photocytotoxicity and metabolomics studies in cancer cells 140
H/D exchange at sp3 carbons in the coordination sphere of platinum(ii) 138
Porphyrin substituted phosphoramidites: New building blocks for porphyrin-oligonucleotide syntheses 136
New chemistry of olefin complexes of platinum(II) unravelled by basic conditions: Synthesis and properties of elusive cationic species 136
xprovax 135
Pentacoordinate [PtCl2(eta(2)-C2H4)(N-N')] complexes with asymmetrically hindered nitrogen donor chelates. Stereospecific synthesis of syn- and anti-[PtCl(eta(1)-CH2CH2OMe)(Mebpy)] 133
Rotamer stability in cis-[Pt(diA)G(2)] complexes (diA = diamine derivative and G = guanine derivative) mediated by carrier-ligand amine stereochemistry as revealed by circular dichroism spectroscopy 131
Stereospecific metal mediated ortho-alkylation of phenols 131
Toward New Potential Antitumor pro-drugs: Cationic Complexes of the type [PtCl(η2-C2H4)(R,R and S,S-DACH)]+ 130
Synthesis, characterization, molecular and crystal structures, chiral solvent induced CD of the new meso ligand, Potassium [cyclic-O,O'-1(R),2(S)-dimethylethylene ditiophosphate], (R)(S)bdtpK and its Nickel(II) complex: Ni[(R)(S)bdtp]2 128
Molecular merging versus molecular linking: the first platinum metalla-chromane complex as a vitamin e biomimetic trojan horse 127
New metastable cationic complexes of the type [PtCl(h2-C2H4)(N-N)]+ as possible antitumor prodrugs 127
Totale 18.911
Categoria #
all - tutte 104.535
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.535


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022669 0 0 0 55 131 22 22 54 36 72 71 206
2022/20233.360 163 216 131 95 149 194 59 118 2.061 8 95 71
2023/20241.404 102 91 72 94 106 125 22 74 202 269 175 72
2024/20253.856 56 40 88 94 259 523 173 147 1.310 302 328 536
2025/20268.518 732 959 838 1.293 832 466 873 302 1.110 601 361 151
2026/20272.392 212 476 428 1.276 0 0 0 0 0 0 0 0
Totale 23.770